Product Information

BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.3785 per EA under NDC 00378876593. Its NADAC has been published 324 times since Jun 10, 2020.

FDA first approved this application on Apr 17, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM

Buprenorphine and Naloxone
$1.3785per EA
DEA Schedule CIII

Strength

2; .5 mg/1; mg/1

NDC

00378876593

Classification

Generic

Dosage Form

FILM

Route

BUCCAL; SUBLINGUAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211785

FDA Approved

4/17/2020

TE Code

AB

On Market Since

4/17/2020

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist
Partial Opioid Agonists

Price Statistics

The NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM has been published 324 times since Jun 10, 2020, and over the history we have for it it has declined 48.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3785 per EA
All-time high$2.7563 (Aug 11, 2021)
All-time low$1.2418 (Nov 20, 2024)
52-week high$1.9156
52-week low$1.2800
Median price$2.2446
Average price$2.1365
Largest weekly change+46.9% (Aug 21, 2024)
Weeks tracked324
Tracking sinceJun 10, 2020

Price History

1W

+5.1%

1M

+5.1%

3M

+5.9%

6M

+2.8%

1Y

-28.0%

3Y

-36.2%

5Y

-46.6%

All

-48.9%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM?

The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM, manufactured by Mylan Pharmaceuticals Inc., is $1.3785 per EA (NDC 00378876593), effective Aug 19, 2026.

How has the price of BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM changed over time?

Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM has declined 48.9%. It has been tracked across 324 weekly CMS publications since Jun 10, 2020.

What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM?

Since Jun 10, 2020, the NADAC for BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM has ranged from a low of $1.2418 (Nov 20, 2024) to a high of $2.7563 (Aug 11, 2021), with a median of $2.2446 per EA.

Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM?

BUPRENORPHINE-NALOXONE 2-0.5 MG SL FILM (NDC 00378876593) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.